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Introduction
Juvenile dermatomyositis (JDM) is a rare autoimmune
disease with the onset in childhood involving chronic
inflammation of striated muscle and skin. The disease is
often leading to severe disability, prolonged decreased
physical activity, which together with chronic inflamma-
tory activity, and long-term medical treatment with glu-
cocorticoids, contributes to the well-known risk factors
for developing osteopenia or osteoporosis. Only a few
studies have followed JDM patients into adulthood.
Objectives
The objective of the present study was to investigate the
long-term outcome on bone mineral status in a Danish
cohort of patients with JDM.
Methods
A total of 49 patients with JDM diagnosed between
1976 and 2005 were investigated. The female/male ratio
was 2.5. The mean age at disease onset was 7 years
(range 1.5-16 years) and the mean disease duration was
3.7 years (range 0.7-9 years). The follow-up time ranged
from 2 years to 36 years (mean 7 years). Bone mass
density (BMD) (g/cm2) was determined by dual X-ray
absorptiometry (DXA).
T- and Z- scores were calculated from BMD. Definition
of osteopenia/osteoporosis in the adult group was accord-
ing to the WHO-criteria: Osteopenia: T-score between
< -1 SD and > -2.5 SD; Osteoporosis: T-score < -2.5 SD.
In the children group < 20 years the guidelines from the
International Society for Clinical Densitometry was used:
Osteopenia: Z-score < -1 SD; Osteoporosis: Z-score
< -2.0 SD.
Results
Forty patients (75%) had a normal DXA-SCAN, 7
patients (13%) had osteopenia and 2 patients (3,8%) had
osteoporosis according to the described definitions.
T-score for adults and Z-score for children were
compared with normal reference values. There were no
significant differences in the adult group. In children
and adolescents younger than 20 years we found no
significant differences in the Z-score of the whole
body, but a marginally reduced Z-score of the lumbar
spine.
The results are listed in Table 1.
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Table 1 Bone Mineral Density Standard Deviation scores
in 49 patients with JDM
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The table presents the mean T- and Z-scores with SDs and range.
*P-values were calculated from the scores with One-Sample T-test
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Conclusion
In this JDM cohort 16.8% of the patients had osteopenia
or osteoporosis. There were no significant differences in
T/Z - scores between the two groups, except for a mar-
ginally reduced Z-score of the lumbar spine scan in the
JDM group younger than 20 years.
The results suggest that clinical follow-up with DXA-
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